Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,120.00
+95.00 (2.36%)
At close: Oct 13, 2026
| Market Cap | 46.00B -26.2% |
| Revenue (ttm) | 19.60B -16.0% |
| Net Income | 3.07B +45.2% |
| EPS | 272.90 +41.3% |
| Shares Out | 11.16M |
| PE Ratio | 15.10 |
| Forward PE | n/a |
| Dividend | 185.00 (4.49%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 4,742 |
| Open | 4,025.00 |
| Previous Close | 4,025.00 |
| Day's Range | 3,870.00 - 4,120.00 |
| 52-Week Range | 3,410.00 - 7,690.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |